BIALX
Price
$30.12
Change
+$0.26 (+0.87%)
Updated
Sep 4 closing price
Net Assets
2.47B
RNPGX
Price
$72.10
Change
+$0.34 (+0.47%)
Updated
Sep 5 closing price
Net Assets
159.21B
Interact to see
Advertisement

BIALX vs RNPGX

Header iconBIALX vs RNPGX Comparison
Open Charts BIALX vs RNPGXBanner chart's image
Brown Advisory Global Leaders Investor
Price$30.12
Change+$0.26 (+0.87%)
VolumeN/A
Net Assets2.47B
American Funds New Perspective R6
Price$72.10
Change+$0.34 (+0.47%)
VolumeN/A
Net Assets159.21B
BIALX vs RNPGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BIALX vs. RNPGX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIALX is a Buy and RNPGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPGX has more cash in the bank: 159B vs. BIALX (2.47B). RNPGX pays higher dividends than BIALX: RNPGX (0.77) vs BIALX (0.33). BIALX was incepted earlier than RNPGX: BIALX (10 years) vs RNPGX (16 years). BIALX (0.91) is less costly to investors than RNPGX (0.41). RNPGX is a more actively managed with annual turnover of: 24.00 vs. BIALX (15.00). BIALX has a lower initial minimum investment than RNPGX: BIALX (100) vs RNPGX (250). RNPGX annual gain was more profitable for investors over the last year : 15.55 vs. BIALX (14.53). BIALX return over 5 years is better than : 68.43 vs. RNPGX (36.85).
BIALXRNPGXBIALX / RNPGX
Total Expense Ratio0.910.41222%
Annual Report Gross Expense Ratio0.910.41222%
Fund Existence10 years16 years-
Gain YTD12.37416.01077%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets2.47B159B2%
Annual Yield % from dividends0.330.7743%
Returns for 1 year14.5315.5593%
Returns for 3 years65.1949.79131%
Returns for 5 years68.4336.85186%
Returns for 10 years220.65100.91219%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX19.440.17
+0.88%
Saratoga Health & Biotechnology A
BHSRX57.770.28
+0.49%
BlackRock Health Sciences Opps R
GOFCX27.580.09
+0.33%
Victory Pioneer Select Mid Cap Growth C
RPMFX16.550.02
+0.12%
Reinhart Genesis PMV Advisor
ETLNX15.560.01
+0.06%
Eventide Large Cap Focus N